Meet Kazia’s management team and hear about paxalisib, Kazia’s lead programme

Meet Kazia’s management team and hear about paxalisib, Kazia’s lead programme

Kazia Therapeutics — 9 videos in collection

Kazia Therapeutics (KZIA) is an oncology-focused drug development company. Its drug candidates are designed to treat cancers which are poorly served by existing therapies.

In this video, James Garner, CEO, introduces Kazia’s expanding US management team: chief medical officer, John Friend, and chief financial officer, Karen Krumeich. John and Karen highlight their experience and what interested them about Kazia. As part of a three-episode Edison TV series, the team also discusses Kazia’s lead asset, paxalisib, a highly potent, small molecule, brain-penetrant inhibitor of PI3K/mTOR, and when we can expect final data from the ongoing Phase III study. Stay tuned for the next video, which focuses on paxalisib beyond glioblastoma.


You may also be interested in these:

Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.